VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $441,000 | -14.0% | 28,116 | -6.1% | 0.02% | -11.8% |
| Q3 2021 | $513,000 | -11.4% | 29,933 | +11.1% | 0.02% | -15.0% |
| Q2 2021 | $579,000 | +43.0% | 26,935 | -0.1% | 0.02% | +42.9% |
| Q1 2021 | $405,000 | +52.3% | 26,973 | +33.4% | 0.01% | +40.0% |
| Q4 2020 | $266,000 | +52.0% | 20,217 | +11.5% | 0.01% | +42.9% |
| Q3 2020 | $175,000 | -10.7% | 18,129 | +5.7% | 0.01% | -22.2% |
| Q2 2020 | $196,000 | -2.0% | 17,145 | -11.4% | 0.01% | 0.0% |
| Q1 2020 | $200,000 | – | 19,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |